Ratings by Evercore ISI (Daniel Markowitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/23/2026 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Outperform (N/A) |
14.35 (14.48) |
0.91% | Details | |
| 3/24/2026 | DexCom | DXCM | Upgrade | Outperform (In Line) |
65.90 (72.47) |
9.97% | Details | |
| 2/27/2026 | Inspire Medical Systems | INSP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2026 | Inspire Medical Systems | INSP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2025 | Insulet Corporation | PODD | New Coverage | Outperform (N/A) |
291.51 (145.76) |
-50% | Details | |
| 11/25/2025 | DexCom | DXCM | New Coverage | In Line (N/A) |
62.21 (65.90) |
5.93% | Details | |
| 11/7/2025 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/27/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 9/22/2025 | Regency Centers | RGEN | Upgrade | Outperform (In Line) |
70.27 (132.02) |
87.88% | Details | |
| 9/16/2025 | TransMedics Group | TMDX | New Coverage | Outperform (N/A) |
114.29 (78.79) |
-31.06% | Details | |
| 9/4/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/2/2025 | Inspire Medical Systems | INSP | New Coverage | Outperform (N/A) |
93.69 (42.61) |
-54.52% | Details | |
| 7/28/2025 | Natera | NTRA | New Coverage | Outperform (N/A) |
138.90 (231.41) |
66.6% | Details | |
| 7/24/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2025 | Repligen | RGEN | Maintain | In Line (N/A) |
|
Details | ||
| 3/18/2025 | West Pharmaceutical | WST | New Coverage | Outperform (N/A) |
230.11 (327.95) |
42.52% | Details | |
| 3/18/2025 | Bio-Techne Corp. | TECH | New Coverage | Outperform (N/A) |
62.16 (57.94) |
-6.79% | Details | |
| 3/18/2025 | Repligen | RGEN | New Coverage | In Line (N/A) |
150.62 (132.02) |
-12.35% | Details |
